Bone marrow transplantation is a treatment option for patients with aplastic anaemia and acute leukaemia.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that bone marrow transplantation is a treatment option for patients with aplastic anaemia and acute leukaemia?

Yes. Bone marrow transplantation (allogeneic hematopoietic stem cell transplantation) is well established as a primary curative treatment option for patients suffering from aplastic anaemia and acute leukaemia.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked 4 Oct 2026

The analysis

The claim is a specific, empirically verifiable medical statement that passes Step 0. Multiple retrieved papers explicitly discuss or report successful outcomes using hematopoietic stem cell/bone marrow transplantation in patients with aplastic anaemia and acute leukaemia, fully supporting the claim with no contradictory evidence.

Evidence for · 4

Haemolytic Anaemia; Beyond Sickle Cell Anaemia: A Case Series of Patients With Paroxysmal Nocturnal Haemoglobinuria in Kenya.

2026

Get citation

M, O., O, L., M, G., & Z, B. (2026). Haemolytic Anaemia; Beyond Sickle Cell Anaemia: A Case Series of Patients With Paroxysmal Nocturnal Haemoglobinuria in Kenya.. doi.org. https://doi.org/10.1155/crh/1756509

See more details

More for · 3

Allogeneic haematopoietic stem cell transplantation for refractory perforating intestinal Behçet disease in a patient with aplastic anaemia: A case report.

2026

Get citation

X, R., X, L., L, D., & Q, W. (2026). Allogeneic haematopoietic stem cell transplantation for refractory perforating intestinal Behçet disease in a patient with aplastic anaemia: A case report.. doi.org. https://doi.org/10.1097/md.0000000000049997

Feasibility and outcomes of kidney transplantation in patients with end-stage kidney disease after haemopoietic stem cell transplantation.

2026

Get citation

B, K., S, C., H, L., HE, Y., H, N., S, P., & BH, C. (2026). Feasibility and outcomes of kidney transplantation in patients with end-stage kidney disease after haemopoietic stem cell transplantation.. doi.org. https://doi.org/10.1111/imj.70459

Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center.

2026

Get citation

K, K., J, G., M, P., E, U., E, K., P, B., A, T., GW, B., & WW, J. (2026). Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center.. doi.org. https://doi.org/10.1007/s12015-026-11241-2

What does the evidence say?

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work